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Objectives: We evaluated the effect of the St Jude Medical sutureless anastomotic
connector on endothelium-dependent and -independent saphenous vein graft relax-
ation, as well as on clinical outcomes and graft patency in patients.
Methods: Human saphenous vein grafts were assigned to control or connector
groups (loaded for 1 or 5 minutes; n  18). Isometric dose-response curves to
endothelium-dependent and -independent (sodium nitroprusside) vasodilators were
constructed in saphenous vein grafts precontracted with phenylephrine. Thrombin-
mediated vasorelaxation, an early determinant of saphenous vein graft failure, was
also evaluated. Percent maximum relaxation was compared between groups. Pa-
tients in whom the St Jude Medical connector was employed underwent clinical
follow-up, stress tests, and angiography 6 to 12 months postoperatively.
Results: A23187-induced endothelium-mediated relaxation, sodium nitroprusside-
induced endothelium-independent relaxation, and thrombin-mediated vasorelax-
ation did not differ between control and connector saphenous vein grafts at either
time point studied. Twenty-seven patients received St Jude Medical connectors.
There was no hospital mortality; patients were followed for 679  241 days. There
was 1 late death; the connector saphenous vein graft was patent at postmortem. All
connector saphenous vein grafts were patent at follow-up angiography. Four grafts
had stenoses (30%-60%), without symptoms or requirement for intervention. All
hand-sewn saphenous vein grafts were also patent.
Conclusions: The St Jude Medical connector does not impair endothelium-depen-
dent vasorelaxation. In patients, patency of the connector saphenous vein grafts 6 to
12 months postoperatively was 100% but 22% of grafts had non–flow-limiting
stenoses at or near the connector. Further long-term studies are required to confirm
the safety of the St Jude Medical connector with regards to endothelial function and
restenosis.
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The development of a facile, reliable alterna-tive to traditional hand-sutured proximal anddistal coronary anastomoses has been pur-sued for some time. These devices may rep-resent an enabling technology for minimalaccess surgery and a facilitating technology
for off-pump surgery, where complete avoidance of aortic
clamping may allow the potential neuropsychological ben-
efits of this strategy1-3 to become evident. However, it must
first be demonstrated that these devices are safe both for the
grafts and for the patients and that they will result in the
same excellent outcomes as traditional hand suturing.
The St Jude Medical (SJM) anastomotic connector cre-
ates a rapid, sutureless anastomosis of a saphenous vein
graft (SVG) to the aorta without aortic manipulation or
clamping.1-5 However, with this device, the saphenous vein
segment must be loaded over the cylindrical delivery sys-
tem, and potential for injury to the SVG endothelium there-
fore exists. Endothelial dysfunction could in turn facilitate
the initiation and continuation of diverse prothrombotic and
proatherosclerotic processes, resulting in accelerated graft
failure, which could negate the advantages of this device.6-8
We therefore evaluated the effect of SVG loading onto the
anastomotic connector system on endothelium-dependent
and -independent function in human SVGs. We also report
the clinical outcomes and angiographic graft patency in our
initial clinical series of patients in whom this sutureless
anastomotic connector was employed.
Methods
Assessment of Endothelial Function
Segments of saphenous veins (n  18, 3-5 cm in length) were
obtained intraoperatively. These veins had undergone careful lim-
ited-pressure manual distension with saline by the operating sur-
geon, as is our usual clinical practice. The segments were placed in
oxygenated physiological salt solution and immediately trans-
ferred to the pharmacology laboratory. The vessels were cleaned of
adherent tissue and cut into segments, with each segment being
randomly and blindly assigned to either the connector or control
group. Segments assigned to the connector group were loaded onto
the SJM connector transfer rod (the portion of the delivery system
with the maximum diameter and greatest potential for endothelial
contact) for a period of 1 or 5 minutes, following which isometric
responses were recorded as described below.
Vascular rings (6 to 9 mm in length) were suspended in
isolated tissue baths (volume 25 mL) containing oxygenated
Krebs-Ringer bicarbonate buffer as described previously.9,10 A
progressive resting tension of 2 to 2.5 g was applied (determined
by preliminary experiments to afford the optimum tension-length
relationship). Following equilibration for 90 minutes, isometric
dose response curves (DRC) were recorded using the following
protocol: (1) cumulative DRC to phenylephrine (108 to 104
mol/L), (2) cumulative DRC to A23187 (109 to 106 mol/L) in
rings precontracted with the effective dose causing 75% of max-
imum phenylephrine (PE)-induced contraction (ED75), (3) cumu-
lative DRC to sodium nitroprusside (SNP; 108 to 105 mol/L) in
rings precontracted with the ED75 of PE. In a separate series of
experiments, we evaluated thrombin (0.1 U/mL)-mediated vasore-
laxation in PE preconstricted veins, as a marker of potential early
graft failure. Vascular rings were allowed to equilibrate between
each DRC for 60 to 90 minutes. All drugs and chemicals were
obtained from Sigma (St Louis, Mo, USA). For all experiments,
isometric force was measured with transducers coupled to MP100
data acquisition software. Data were analyzed off-line and ex-
pressed as mean  SEM. Percent maximum relaxation (%Emax)
and agonist sensitivity (pEC50) were compared between interven-
tions. pEC50 values were calculated as the negative log of molar
ED50. Nonlinear analysis of the individual dose-response curves
was performed, and the obtained pEC50 values were averaged.
Dose-response curves were compared by means of repeated-mea-
sures analysis of variance. Differences between mean values were
considered statistically significant when P  .05.
Clinical Evaluation
Patients undergoing isolated primary coronary artery bypass graft-
ing (CABG), whether on-pump or off-pump, were eligible to
participate in this study. All patients gave informed consent to a
clinical investigational protocol approved by our institutional Re-
search Ethics Board. The SJM connector was employed primarily
in SVGs to the right coronary artery (RCA) territory and was
loaded and deployed as per manufacturer’s specifications. Patients
underwent standard clinical follow-up in addition to exercise stress
tests at 6 weeks and 3 months and angiography of all SVGs 6 to 12
months postoperatively. Left internal thoracic artery grafts were
not injected at the time of angiography except in patients with
suggestive symptoms or positive stress tests to minimize the risk of
internal thoracic artery graft injury during angiography.
Results
Endothelial Function
SVGs from 18 patients were evaluated. The internal diam-
eter was similar between groups [control 3.0  0.04 mm;
connector (1-minute loading) 3.1  0.6 mm; connector
(5-minute loading) 3.3  0.1 mm; P  .6]. Figure 1 depicts
the effects of the SJM connector on endothelium-dependent
and -independent vascular responses to A23187 and SNP,
respectively. A23187 and SNP caused dose-dependent va-
sorelaxation in all vessels studied; vascular responses re-
mained unaffected by intraluminal exposure to the connec-
tor for either 1 or 5 minutes [A23187: control (%Emax 24%
 3%; pEC50 6.8  0.07); connector, 1-minute loading
(%Emax 19% 4%; pEC50 7.0 0.05); connector, 5-minute
loading (%Emax 16%  6%; pEC50 7.1  0.12); P  .5].
Figure 2 depicts the effects of thrombin on percent maxi-
mum relaxation in PE preconstricted vascular rings. Throm-
bin-mediated vasorelaxation, a surrogate marker of early
endothelial damage and thrombogenicity, remained un-
changed in SVGs exposed to the connector for either 1 or 5
minutes [%Emax control 35%  5%; connector (1-minute
loading) 25%  7%; connector (5-minute loading) 24% 
5%; P  .2].
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Early Clinical Outcomes
Of the 44 patients who consented to the clinical study, 17
were excluded intraoperatively. In 16 of these excluded
patients, the saphenous vein segment was found to be of
inadequate caliber (measured by external diameter, OD) for
the connector delivery systems available. Early in our ex-
perience, only systems for vein grafts with external diame-
ters of 5.0 to 5.5 mm and 5.5 to 6.0 mm were available;
intraoperative exclusions declined significantly when the
delivery system for veins with OD 4.5 to 5.0 mm became
available. One patient was excluded intraoperatively after
median sternotomy was performed and matted mediastinal
lymph nodes were found. A previously clinically and radio-
graphically undetected primary lung carcinoma was identi-
fied in this patient, who was withdrawn from the protocol at
that time.
Twenty-seven patients received anastomotic connectors.
The mean diameter of the connector SVGs was 5.2  0.3
mm, and mean diameter of the target coronary arteries was
1.6  0.3 mm. The SVG segments were loaded onto the
delivery system by the operating surgeon, requiring 5  3
minutes.
In this series, there were 2 deployment failures. In 1
patient, a connector was deployed without problems but the
proximal anastomosis was noted to be leaking at 1 pinpoint
site. In accordance with manufacturer’s recommendations,
the connector was manually removed and the aortotomy
enlarged slightly with a standard aortic punch. The proximal
end of the vein graft, to which the connector was affixed,
was amputated and a hand-sewn anastomosis was created
without problems. In a second patient, the connector was
fired without incident but was not retained within the aorta
on withdrawal of the delivery system. A hand-sewn anastomo-
sis was also performed without difficulty. The manufacturer’s
quality control department evaluated both of the explanted
connectors and no device-related issues were identified.
There was no hospital mortality in this series. No patient
suffered a perioperative myocardial infarction, stroke, or
required reexploration for bleeding.
Mid-Term Clinical Outcomes
Patients were followed for 679  241 days (median 778
days) and clinical follow-up was complete. There was 1 late
death, in a patient who had an 80% left main stenosis,
Figure 2. Percent maximum relaxation to thrombin (0.1 u/mL), in
saphenous vein grafts preconstricted with the ED75 of phenyleph-
rine. Thrombin-mediated vasorelaxation, an early marker of vein
graft thrombogenicity, remained unchanged following exposure
to the aortic anastomotic connector (AAC) for a period of 1 or 5
minutes (AAC 1 and AAC 5, respectively; P  .21).
Figure 1. Vascular responses in segments of saphenous vein grafts exposed to the aortic anastomotic connector
(AAC). A, Endothelium-dependent vasodilatation to A23187 in saphenous vein grafts exposed to the AAC for 1
minute (AAC 1) or 5 minutes (AAC 5) versus control. Maximum relaxation was evaluated in veins preconstricted
with the ED75 of phenylephrine (see Methods). A23187 caused dose-dependent vasorelaxation; this effect was
similar between groups (P  .53). B, Endothelium-independent vasorelaxation to sodium-nitroprusside was also
similar between groups (P  .47). The use of the AAC for up to 5 minutes does not impair endothelium-dependent
or -independent vascular responses.
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diffuse triple vessel disease, and peripheral vascular disease
precluding the use of an internal thoracic artery graft. At the
time of surgery, he was found to have an atherosclerotic
aorta and ungraftable coronaries save for a left anterior
descending (LAD) coronary artery. A single vein graft was
constructed to the LAD using the anastomotic connector.
His postoperative course in hospital was uneventful but he
died during the follow-up period. A postmortem was ob-
tained and the connector SVG was found to be patent.
No patient had recurrent or persistent angina during
follow-up, and none required repeat revascularization pro-
cedures.
Angiographic Outcomes
Two patients, both of whom were free of angina postoper-
atively, declined to return for angiography. In addition, 2
elderly patients residing in nursing homes who had signif-
icant renal failure were felt not to be candidates for post-
operative study angiography. Neither has had angina or a
positive stress test.
The 18 other patients underwent graft angiography 6 to
12 months postoperatively. The patency of the connector
SVGs was 100% (18/18 grafts). Four grafts (22%), how-
ever, had stenoses (30%, 50%, 50%, 60%), without symp-
toms or requirement for further intervention. All stenoses
occurred at or within 3 cm of the proximal anastomosis
(Figure 3).
The patency of hand-sutured SVGs was also 100%
(24/24 grafts). No stenoses were observed in the proximal
portions of the hand-sewn grafts. Three patients had their
left internal thoracic artery grafts injected at angiography;
all were patent.
Discussion
The technology employed in the current generation of aortic
anastomotic connectors poses the theoretical concern of
causing endothelial damage with resultant endothelial cell
dysfunction. Endothelial dysfunction is a broad term that
implies diminished production/availability of nitric oxide
and/or an imbalance in the relative contribution of endothe-
lium-derived relaxing and contracting factors (such as en-
dothelin-1, angiotensin, and oxidants).11-13 It is well ac-
cepted that endothelial dysfunction precedes the
development of atherosclerosis. Endothelial dysfunction ac-
tively partakes in the process of lesion formation by pro-
moting the early and late mechanisms of atherosclerosis.
These include up-regulation of adhesion molecules, in-
creased chemokine secretion and leukocyte adherence, in-
creased cell permeability, enhanced low-density lipoprotein
oxidation, platelet activation, cytokine elaboration, and fi-
nally vascular smooth muscle cell proliferation and migra-
tion. In addition to participating in the development of
atherosclerosis, endothelial dysfunction plays an important
role in the clinical course of the disease. Impaired endothe-
lium-dependent vasodilatation in atherosclerotic vessels re-
sults in paradoxical vasoconstriction, which may result in
reduced myocardial perfusion and myocardial ischemia.
Hence, disruption of normal endothelial function results in
diverse effects including vasoconstriction, leukocyte adher-
Figure 3. Angiographic appearance of (A) a widely patent connector graft and (B) a graft with a stenosis at the
level of the connector, possibly due to intimal hyperplasia.
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ence, platelet activation, mitogenesis, pro-oxidation, throm-
bosis, impaired coagulation, vascular inflammation, and
atherosclerosis.
Given the importance of endothelial function to short-
and long-term vascular homeostasis, any effect of the con-
nector to cause endothelial dysfunction might negate its
potential benefits. Our data suggest that loading SVGs on
the connector for up to 5 minutes under the conditions
employed does not result in changes in endothelium-depen-
dent or -independent vascular responses over and above
those observed merely due to the standard clinical practice
of careful, low-pressure manual distension. Importantly,
thrombin-mediated vasorelaxation, a marker of early throm-
bogenicity, also remained unaltered in SVGs subjected to
the SJM connector for 5 minutes. The 5-minute time point
coincides with the mean loading time in the clinical expe-
rience presented in this series. Because acutely measured
endothelial function predicts long-term atherosclerotic vas-
cular disease,14 these data suggest that short-term exposure
of SVGs to the connector may have limited effect on graft
atherosclerosis. Whether longer exposure times may result
in endothelial dysfunction remains to be determined.
The SJM anastomotic connector can be used to rapidly
and reproducibly create proximal anastomoses for SVGs.
The current generation of this technology requires the im-
planting surgeon to pay close attention to a number of
issues. These proximal anastomoses are constructed at 90°
angles from the aorta, and in our series, connectors were
therefore generally employed for grafts to the RCA terri-
tory. Connectors can also be employed for left-sided grafts,
but positioning of the anastomosis on the lateral wall of the
ascending aorta is critical to avoid kinking of the graft either
by the pulmonary artery or by the pericardium. Sizing of the
vein, avoidance of excessively thick-walled segments, and
careful loading are key.
One of the most important aspects of this technology is
the availability of an easy “bailout” procedure should the
device fail to perform as desired. With this connector,
nonhemostatic anastomoses that cannot be repaired can be
resolved simply by manual traction on the connector graft
until the connector is dislodged from the aorta. In our
experience, this was easily performed and did not result in
visible trauma to the aortotomy. Reuse of the previously
loaded vein segment can be accomplished either with a
hand-sewn anastomosis or reloading and deployment of
another anastomotic connector. In our series, early in the
worldwide clinical experience with this device, we followed
the manufacturer’s recommendations to revert to hand-sewn
anastomoses in the case of any deployment failure. Cur-
rently, a connector that was leaking at a single point would
be repaired with a simple suture, and a vein that was not
retained in the aorta on deployment would simply be re-
loaded onto another system and redeployed.
The 100% patency rate of the connector grafts (and the
hand-sewn grafts) is reassuring, although there are insuffi-
cient numbers to make meaningful comparisons to the an-
ticipated 85% to 90% patency of SVGs in historical series.
If there is any inference that can be drawn from the 100%
patency of both the connector and the hand-sutured vein
grafts observed in this study, it may be that current anti-
platelet and lipid-lowering therapies have favorably im-
pacted early graft patency compared with historical con-
trols.
Not all grafts in which the connector was employed were
perfect, however. Four grafts demonstrated mild to moder-
ate stenoses, all at or within 3 cm of the proximal anasto-
mosis. In one graft, a stenosis 2 to 3 cm distal to the
connector may have been due to partial kinking after its 90°
origin. In the other 3 stenotic grafts, intimal hyperplasia
appeared to be the most likely cause. During the process of
loading, the segment of vein closest to the aorta may un-
dergo the most manipulation and consequent contact of the
endothelium with the delivery system. If this is a significant
factor, intimal hyperplasia may be expected to be most
marked in the proximal segment of the vein graft, where the
stenoses were observed in this series. Our laboratory data
did not suggest, however, that intraluminal exposure of the
vein graft to the connector delivery system was associated
with detectable endothelial injury under the experimental
conditions employed. More traumatic loading conditions
might have been associated with demonstrable endothelial
injury.
These graft stenoses did not appear, at the time of post-
operative angiography, to be significantly flow-limiting in
nature. However, no physiologic studies of the grafts were
performed, and their late significance therefore remains
unknown. In this study, at a median duration of follow-up of
more than 2 years, none of these patients, and specifically
none of the patients with stenotic connector grafts, had had
any recurrence of angina. Ongoing follow-up will clarify
whether the stenoses observed are stable in behavior or
whether they may progress to become hemodynamically
significant lesions.
Limitations of This Study
Endothelial function can be adversely influenced by a num-
ber of factors, including patient comorbidities and intraop-
erative technique. The primary purpose of this study was to
evaluate the effects of the aortic anastomotic connector on
endothelial function when used in the conventional setting,
which includes loading of a vein segment, after careful
low-pressure manual distension, onto the transfer rod. Al-
though loading of a nondistended vein may impair endothe-
lium-dependent vasorelaxation compared with baseline, this
experimental model does not correspond to the clinical
scenario of loading following careful manual distension.
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Therefore, our results suggest that the aortic anastomotic
connector does not impair endothelial function over and
above standard intraoperative distension. Although we did
not observe any difference in functional endothelial capac-
ity between vein segments loaded onto the connector system
and control segments, our current data cannot exclude the
possibility of changes in endothelial morphology and ori-
entation microscopically. Our findings, however, do suggest
that there is no additional damage to endothelial “function”
when veins that have been carefully distended as per stan-
dard clinical practice are loaded onto the St Jude aortic
anastomotic connector. We have corrected the responses in
terms of grams of tension per cross-sectional area (mm2).
This correction allows us to carefully evaluate the effects of
tension evoked as a function of vascular smooth muscle
content and demonstrated no difference between groups
(tension at maximum A23187 control 2.03 g/mm2 vs aortic
anastomotic connector 1.94 g/mm2, P NS). It is important
to recognize that the experimental conditions employed did
not exactly mimic the piercing, rolling, and pressing on the
vein segment that occurs intraoperatively as it is being
loaded. However, our protocol did evaluate the effects of
radial stretching by introduction of the loading device on
endothelial functional reserve. Lastly, conclusive evidence
of endothelial safety can only be determined by evaluating
the long-term effects of the connector on endothelial func-
tion in a chronic animal model of vein graft interposition.
Such further studies will be required to carefully define
endothelial safety.
Future Developments
This anastomotic technology is likely to find the greatest
application in patients undergoing off-pump CABG, in
whom the availability of such a device makes application of
a partial occlusion clamp on the aorta unnecessary.1-3 If
there is a benefit of avoidance of cardiopulmonary bypass
on neuropsychological sequelae in patients, it may well be
demonstrable only when the aorta is never clamped, and
particulate emboli from an atherosclerotic aorta do not
contribute to neuropsychological deficits. These connectors
also are ideal for minimal-access surgery and may facilitate
the ongoing development of these less-invasive approaches.
Finally, these devices may reduce the mediastinal dissection
and aortic access required in patients undergoing reopera-
tive CABG.
As this technology evolves, the next generations of these
devices are likely to be significantly easier and quicker to
load and deploy, to permit construction of distal anastomo-
ses prior to proximals, and to be safe to use on arterial
conduits.15 However, ongoing studies to evaluate the mid-
term and late effects of these devices on graft patency will
be required to fully document their advantages and limita-
tions.
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